110 related articles for article (PubMed ID: 36300981)
1. Audio Interview: Assessing the Effect of Vaccination and Prior SARS-CoV-2 Infection.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2022 Oct; 387(17):e50. PubMed ID: 36300981
[No Abstract] [Full Text] [Related]
2. Audio Interview: Antibody Responses to Natural Infection and Vaccination.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2021 Apr; 384(14):e65. PubMed ID: 33826826
[No Abstract] [Full Text] [Related]
3. Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma.
Lim SH; Campbell N; Johnson M; Joseph-Pietras D; Collins GP; O'Callaghan A; Fox CP; Ahearne M; Johnson PWM; Goldblatt D; Davies AJ
Lancet Haematol; 2021 Aug; 8(8):e542-e544. PubMed ID: 34224667
[No Abstract] [Full Text] [Related]
4. Hybrid Immunity More Protective Than Prior SARS-CoV-2 Infection Alone.
Larkin H
JAMA; 2023 Feb; 329(7):531. PubMed ID: 36723971
[No Abstract] [Full Text] [Related]
5. [Vaccination immunology in SARS-CoV-2].
Helweg-Larsen J; Benfield T
Ugeskr Laeger; 2021 Mar; 183(11):. PubMed ID: 33734074
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 infection confers greater immunity than shots.
Wadman M
Science; 2021 Sep; 373(6559):1067-1068. PubMed ID: 34516858
[No Abstract] [Full Text] [Related]
7. Measuring cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine (BNT126b2) in patients on maintenance haemodialysis.
Martin P; Clarke C
EBioMedicine; 2021 Sep; 71():103567. PubMed ID: 34454401
[No Abstract] [Full Text] [Related]
8. Serological response in health care workers after a single dose of SARS-CoV-2 vaccine using six automated SARS-CoV-2 antibody assays.
Cuykx M; Mortelé O; Jansens H; Schouwers S; Meskal A; Hoffbauer I; Peeters B
Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115486. PubMed ID: 34332306
[TBL] [Abstract][Full Text] [Related]
9. A Possible Role for Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination.
Murphy WJ; Longo DL
N Engl J Med; 2022 Jan; 386(4):394-396. PubMed ID: 34818473
[No Abstract] [Full Text] [Related]
10. [Immune memory against SARS-CoV-2: Antibodies against the initial infection and memory B cells for the future ones].
Reynaud CA; Weill JC; Chappert P; Mahévas M
Med Sci (Paris); 2021; 37(8-9):722-725. PubMed ID: 34346865
[No Abstract] [Full Text] [Related]
11. Comparison of neutralizing antibody responses against SARS-CoV-2 in healthy volunteers who received the BNT162b2 mRNA or the AZD1222 vaccine: Should the second AZD1222 vaccine dose be given earlier?
Terpos E; Trougakos IP; Karalis V; Ntanasis-Stathopoulos I; Sklirou AD; Bagratuni T; Papanagnou ED; Patseas D; Gumeni S; Malandrakis P; Korompoki E; Dimopoulos MA
Am J Hematol; 2021 Sep; 96(9):E321-E324. PubMed ID: 34028867
[No Abstract] [Full Text] [Related]
12. Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273.
Steensels D; Pierlet N; Penders J; Mesotten D; Heylen L
JAMA; 2021 Oct; 326(15):1533-1535. PubMed ID: 34459863
[TBL] [Abstract][Full Text] [Related]
13. Audio Interview: How Well Are Covid-19 Vaccines Working?
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2021 Jul; 385(2):e15. PubMed ID: 34233102
[No Abstract] [Full Text] [Related]
14. Presence of SARS-CoV-2 antibodies in lactating women and their infants following BNT162b2 messenger RNA vaccine.
Schwartz A; Nir O; Toussia-Cohen S; Leibovich L; Strauss T; Asraf K; Doolman R; Sharabi S; Cohen C; Levin EG; Lustig Y; Regev-Yochay G; Yinon Y
Am J Obstet Gynecol; 2021 Nov; 225(5):577-579. PubMed ID: 34352250
[No Abstract] [Full Text] [Related]
15. Low titers of SARS-CoV-2 neutralizing antibodies after first vaccination dose in cancer patients receiving checkpoint inhibitors.
Terpos E; Zagouri F; Liontos M; Sklirou AD; Koutsoukos K; Markellos C; Briasoulis A; Papanagnou ED; Trougakos IP; Dimopoulos MA
J Hematol Oncol; 2021 May; 14(1):86. PubMed ID: 34059088
[TBL] [Abstract][Full Text] [Related]
16. Previous Infection Combined with Vaccination Produces Neutralizing Antibodies with Potency against SARS-CoV-2 Variants.
Ibarrondo FJ; Hofmann C; Ali A; Ayoub P; Kohn DB; Yang OO
mBio; 2021 Dec; 12(6):e0265621. PubMed ID: 34872349
[TBL] [Abstract][Full Text] [Related]
17. Audio Interview: How Much Protection Does Prior SARS-CoV-2 Infection Provide?
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2021 Dec; 385(25):e100. PubMed ID: 34910868
[No Abstract] [Full Text] [Related]
18. A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies.
Sánchez-Zuno GA; Matuz-Flores MG; González-Estevez G; Nicoletti F; Turrubiates-Hernández FJ; Mangano K; Muñoz-Valle JF
Int J Immunopathol Pharmacol; 2021; 35():20587384211050199. PubMed ID: 34632844
[TBL] [Abstract][Full Text] [Related]
19. Endemic SARS-CoV-2 will maintain post-pandemic immunity.
Veldhoen M; Simas JP
Nat Rev Immunol; 2021 Mar; 21(3):131-132. PubMed ID: 33402727
[TBL] [Abstract][Full Text] [Related]
20. T cell immunity to SARS-CoV-2 following natural infection and vaccination.
DiPiazza AT; Graham BS; Ruckwardt TJ
Biochem Biophys Res Commun; 2021 Jan; 538():211-217. PubMed ID: 33190827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
